레스메드(RMD)는 NYSE에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $224.99 (-1.50%), 시가총액 $30.31B, PER (주가수익비율) 20.15, 52주 최저~최고 $198.76 ~ $293.73.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and
레스메드의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
레스메드의 현재 주가는 $224.99 (-1.50%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
레스메드의 시가총액은 약 $30.31B입니다. PER은 20.15입니다.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and interna